Analyze Diet
Journal of equine science2009; 19(4); 91-95; doi: 10.1294/jes.19.91

Effect of Low-Dose Human Interferon-alpha on Shipping Fever of Thoroughbred Racehorses.

Abstract: To assess the effect of human interferon-alpha (IFNα) on shipping fever of Thoroughbred racehorses subjected to long-distance transportation, an IFNα preparation was orally administered to 48 horses three times (once daily, 3 successive days) before transportation (IFNα group). In the control group (25 horses), maltose was administered in the same way. These treatments induced no abnormal findings in Thoroughbred racehorses before transportation. Immediately after transportation, significant increases in rectal temperature were observed in both treatment groups, whereas the rectal temperature of the IFNα group tended to be lower than that of the control group. Although WBC, Fbg, and SAA immediately after transportation were significantly increased due to transportation in both groups, the extent of the increases in the IFNα group was significantly smaller than in the control group. Long-distance transportation had a relatively profound impact on Thoroughbred racehorses, which was mitigated by IFNα treatment.
Publication Date: 2009-01-09 PubMed ID: 24833959PubMed Central: PMC4013948DOI: 10.1294/jes.19.91Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers conducted a study to investigate the impact of human interferon-alpha (IFNα) on the shipping fever in Thoroughbred racehorses throughout long-distance transport. They found that the treatment substantially mitigated the stress induced by the journey, evident in the horses’ vital signs such as rectal temperature and white blood cells count.

Study Design and Methodology

  • The scientists conducted an experimental study featuring two groups of thoroughbred racehorses. They introduced IFNα to one group (48 horses) and maltose as a control to the other (25 horses). The preparation for the test was done over three consecutive days, with each horse receiving oral doses once a day.
  • The parameters measured included rectal temperature, white blood cell count (WBC), fibrinogen (Fbg), and serum amyloid A (SAA), which were all taken before and after the transportation.

Findings from the study

  • No abnormal findings were observed in the horses prior to the transportation, meaning the dosage of either IFNα or maltose produced no immediate negative health effects.
  • Both treatment groups experienced an increase in rectal temperatures immediately after transportation, indicating that long-distance travel introduced stress for the horses. However, the IFNα group showed a less significant rise in temperature compared to the control group.
  • Similarly, WBC, Fbg, and SAA levels immediately after transportation increased significantly in both groups. This is a typical physiological response to stress, as these parameters are indicators of inflammation in the body. Yet, the extent of the increases in the IFNα group was significantly less than the control group.

Conclusion from the study

  • The results of the study suggest that low-dose human interferon-alpha (IFNα) can mitigate the impact of long-distance transportation stress on Thoroughbred racehorses, as evidenced by the smaller increases in rectal temperatures and inflammation indicators (WBC, Fbg, and SAA). This could potentially improve the overall well-being of the horses during transportation, which is particularly advantageous for racehorses that frequently undergo long-distance travel.

Cite This Article

APA
Akai M, Hobo S, Wada S. (2009). Effect of Low-Dose Human Interferon-alpha on Shipping Fever of Thoroughbred Racehorses. J Equine Sci, 19(4), 91-95. https://doi.org/10.1294/jes.19.91

Publication

ISSN: 1340-3516
NlmUniqueID: 9503751
Country: Japan
Language: English
Volume: 19
Issue: 4
Pages: 91-95

Researcher Affiliations

Akai, Makoto
  • Racehorse Clinic, Ritto Training Center, Japan Racing Association, 2500-2 Mikoma, Ritto-shi, Shiga 520-3085, Japan.
Hobo, Seiji
  • Microbiology Division, Epizootic Research Center, Equine Research Institute, Japan Racing Association, 1400-4 Shiba, Shimotsuke-shi, Tochigi 329-0412, Japan.
Wada, Shinya
  • Racehorse Clinic, Ritto Training Center, Japan Racing Association, 2500-2 Mikoma, Ritto-shi, Shiga 520-3085, Japan.

References

This article includes 13 references
  1. Cummins JM, Beilharz MW, Krakowka S. Oral use of interferon.. J Interferon Cytokine Res 1999 Aug;19(8):853-7.
    pubmed: 10476928doi: 10.1089/107999099313352google scholar: lookup
  2. Eid P, Meritet JF, Maury C, Lasfar A, Weill D, Tovey MG. Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics.. J Interferon Cytokine Res 1999 Feb;19(2):157-69.
    pubmed: 10090401doi: 10.1089/107999099314306google scholar: lookup
  3. Gutterman JU. Cytokine therapeutics: lessons from interferon alpha.. Proc Natl Acad Sci U S A 1994 Feb 15;91(4):1198-205.
    pmc: PMC43124pubmed: 8108387doi: 10.1073/pnas.91.4.1198google scholar: lookup
  4. Hobo S, Oikawa M, Kuwano A, Yoshida K, Yoshihara T. Effect of transportation on the composition of bronchoalveolar lavage fluid obtained from horses.. Am J Vet Res 1997 May;58(5):531-4.
    pubmed: 9140563
  5. Hobo S, Tomita T, Nambo Y, Anzai T. Preventive effect of low-dose interferon alpha oral medication against shipping fever in thoroughbreds. J. Jap. Vet. Assoc. 2006;59:741–745.
  6. Hobo S, Niwa H, Anzai T. Evaluation of serum amyloid A and surfactant protein D in sera for identification of the clinical condition of horses with bacterial pneumonia.. J Vet Med Sci 2007 Aug;69(8):827-30.
    pubmed: 17827889doi: 10.1292/jvms.69.827google scholar: lookup
  7. Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis.. N Engl J Med 1997 Jan 30;336(5):347-56.
    pubmed: 9011789doi: 10.1056/nejm199701303360507google scholar: lookup
  8. McCaw DL, Boon GD, Jergens AE, Kern MR, Bowles MH, Johnson JC. Immunomodulation therapy for feline leukemia virus infection.. J Am Anim Hosp Assoc 2001 Jul-Aug;37(4):356-63.
    pubmed: 11450836doi: 10.5326/15473317-37-4-356google scholar: lookup
  9. Moore BR, Krakowka S, Cummins JM, Robertson JT. Changes in airway inflammatory cell populations in standardbred racehorses after interferon-alpha administration.. Vet Immunol Immunopathol 1996 Jan;49(4):347-58.
    pubmed: 8677636doi: 10.1016/0165-2427(95)05480-4google scholar: lookup
  10. Oikawa M, Kamada M, Yoshikawa Y, Yoshikawa T. Pathology of equine pneumonia associated with transport and isolation of Streptococcus equi subsp. zooepidemicus.. J Comp Pathol 1994 Aug;111(2):205-12.
    pubmed: 7806706doi: 10.1016/s0021-9975(05)80052-0google scholar: lookup
  11. Oikawa M, Hobo S, Oyamada T, Yoshikawa H. Effects of orientation, intermittent rest and vehicle cleaning during transport on development of transport-related respiratory disease in horses.. J Comp Pathol 2005 Feb-Apr;132(2-3):153-68.
    pubmed: 15737342doi: 10.1016/j.jcpa.2004.09.006google scholar: lookup
  12. Tompkins WA. Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action.. J Interferon Cytokine Res 1999 Aug;19(8):817-28.
    pubmed: 10476925doi: 10.1089/107999099313325google scholar: lookup
  13. Weiss RC, Cummins JM, Richards AB. Low-dose orally administered alpha interferon treatment for feline leukemia virus infection.. J Am Vet Med Assoc 1991 Nov 15;199(10):1477-81.
    pubmed: 1666107

Citations

This article has been cited 3 times.
  1. Nielsen SS, Alvarez J, Bicout DJ, Calistri P, Canali E, Drewe JA, Garin-Bastuji B, Gonzales Rojas JL, Gortázar Schmidt C, Michel V, Miranda Chueca MÁ, Padalino B, Pasquali P, Roberts HC, Spoolder H, Stahl K, Velarde A, Viltrop A, Winckler C, Earley B, Edwards S, Faucitano L, Marti S, Miranda de La Lama GC, Costa LN, Thomsen PT, Ashe S, Mur L, Van der Stede Y, Herskin M. Welfare of equidae during transport. EFSA J 2022 Sep;20(9):e07444.
    doi: 10.2903/j.efsa.2022.7444pubmed: 36092762google scholar: lookup
  2. Frazzini S, Riva F, Amadori M. Therapeutic and Prophylactic Use of Oral, Low-Dose IFNs in Species of Veterinary Interest: Back to the Future. Vet Sci 2021 Jun 11;8(6).
    doi: 10.3390/vetsci8060109pubmed: 34208413google scholar: lookup
  3. Endo Y, Tsuchiya T, Omura T, Nakai K, Korosue K, Ishimaru M, Ishikawa Y, Hobo S. Effects of pre-shipping marbofloxacin administration on fever and blood properties in healthy Thoroughbreds transported a long distance. J Vet Med Sci 2015 Jan;77(1):75-9.
    doi: 10.1292/jvms.14-0336pubmed: 25720808google scholar: lookup